Sarasota, FL—September 15, 2017—The Roskamp Institute is pleased to announce that the first annual Grey Matters Symposium on Alzheimer’s Disease Research has sold out. Recent stats show that 1 in 9 people age 65 and older have Alzheimer’s dementia. By 2050, it is estimated that as many as 16 million Americans will have Alzheimer’s disease, with 135 million people being affected worldwide. The emotional and financial costs of lives lost, families affected, and care needed is staggering. Speakers at this interactive luncheon will be presenting on various areas of brain health, potential treatments and information on prevention due to healthy lifestyle choices to provide the audience with facts, preventative measures, early symptom warnings and clinical research updates regarding the potential for new treatments being developed at the Roskamp Institute and elsewhere.
The world-renowned speakers/panelists include: President & CEO of the Roskamp Institute, Dr. Fiona Crawford, Executive Director of the Roskamp Institute, Dr. Michael Mullan and Dr. Michael Murray N.D., Chief Science Officer at Enzymedica & internationally acclaimed authority on natural medicine. The panel moderator will be Hayley Wielgus, ABC 7. A few notable sponsors include: The Community Foundation of Sarasota County, Ursella H. Selliti Charitable Fund, Gresham and Ruth Roskamp, Enzymedica Inc., Sarasota Bay Club, Jacaranda Trace and Williams Parker Attorneys at Law.
After establishing research facilities locally in 2003, the Roskamp Institute has made important discoveries with profound clinical implications for millions of Americans suffering Alzheimer’s and other debilitating neurological disorders.
The Institute has become firmly established as a leading not-for-profit, independent body in the international research community with its programs and projects supported by the National Institutes of Health, the U.S. Department of Defense, the Veterans Administration, the European Commission Seventh Framework Programme and several other national and international peer reviewed agencies.
The Institute focuses on, in addition to Alzheimer’s Disease treatments, the development of new drugs and therapies to treat neurological disorders such as Traumatic Brain Injury, Gulf War Illness, Multiple Sclerosis and other neuroinflammatory disorders.
“We are so thrilled with the outpouring of support for our Grey Matters event. The level of interest speaks to the fact that Alzheimer’s impacts so many people in so many ways,” said Institute CEO, Dr. Fiona Crawford. “Our work at the Institute is translating to new treatments and cures for Alzheimer’s and related brain disorders.” Funds received from The Grey Matters Symposium provide direct monetary support to current scientifically based-medical research being conducted at The Roskamp Institute.
Tickets start at $50. To be added to the wait list please call (941) 552-9832. For more information on next year’s event please contact Megan Micale at [email protected] or 941.552-9832.
Check out this video to see a little more about what is currently happening at The Institute
INFORMATION ON NEXT YEARS EVENT:
Find information on next year’s Grey Matters Event at RoskampInstitute.org
ABOUT THE ROSKAMP INSTITUTE
The Roskamp Institute’s mission is understanding causes and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. The Institute utilizes a broad range of highly advanced scientific approaches to understand the causes of, and potential therapies for, these disorders. From this work novel treatments developed by the Roskamp Institute have been clinically tested in Europe and the U.S. If you wish to sponsor or learn more about our critical research, please visit www.roskampinstitute.org. To take a tour of the laboratories and facilities please call (941) 752-2949.